206 related articles for article (PubMed ID: 27242527)
1. Rifaximin Improves Clostridium difficile Toxin A-Induced Toxicity in Caco-2 Cells by the PXR-Dependent TLR4/MyD88/NF-κB Pathway.
Esposito G; Nobile N; Gigli S; Seguella L; Pesce M; d'Alessandro A; Bruzzese E; Capoccia E; Steardo L; Cuomo R; Sarnelli G
Front Pharmacol; 2016; 7():120. PubMed ID: 27242527
[TBL] [Abstract][Full Text] [Related]
2. Lathyrus sativus diamine oxidase reduces Clostridium difficile toxin A-induced toxicity in Caco-2 cells by rescuing RhoA-GTPase and inhibiting pp38-MAPK/NF-κB/HIF-1α activation.
Pietrangeli P; Corpetti C; Seguella L; Del Re A; Pesce M; Vincenzi M; Lori C; Annunziata G; Mateescu MA; Sarnelli G; Esposito G; Marcocci L
Phytother Res; 2021 Jan; 35(1):415-423. PubMed ID: 32914548
[TBL] [Abstract][Full Text] [Related]
3. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro.
Wang W; Xia T; Yu X
Inflamm Res; 2015 Jun; 64(6):423-31. PubMed ID: 25917044
[TBL] [Abstract][Full Text] [Related]
4. Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
Esposito G; Gigli S; Seguella L; Nobile N; D'Alessandro A; Pesce M; Capoccia E; Steardo L; Cirillo C; Cuomo R; Sarnelli G
Int J Oncol; 2016 Aug; 49(2):639-45. PubMed ID: 27279570
[TBL] [Abstract][Full Text] [Related]
5. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
[TBL] [Abstract][Full Text] [Related]
7. Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
Yang Y; Sheng Y; Wang J; Zhou X; Guan Q; Shen H; Li W; Ruan S
J Cell Mol Med; 2021 Aug; 25(15):7257-7269. PubMed ID: 34184406
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by
Gigli S; Seguella L; Pesce M; Bruzzese E; D'Alessandro A; Cuomo R; Steardo L; Sarnelli G; Esposito G
United European Gastroenterol J; 2017 Dec; 5(8):1108-1115. PubMed ID: 29238589
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.
Cheng J; Shah YM; Ma X; Pang X; Tanaka T; Kodama T; Krausz KW; Gonzalez FJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):32-41. PubMed ID: 20627999
[TBL] [Abstract][Full Text] [Related]
10. The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.
Hansen A; Alston L; Tulk SE; Schenck LP; Grassie ME; Alhassan BF; Veermalla AT; Al-Bashir S; Gendron FP; Altier C; MacDonald JA; Beck PL; Hirota SA
PLoS One; 2013; 8(11):e81491. PubMed ID: 24278446
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of Palmitic Acid-Induced Intestinal Epithelial Barrier Dysfunction by 6-Shogaol in Caco-2 Cells: The Role of MiR-216a-5p/TLR4/NF-κB Axis.
Ouyang F; Li B; Wang Y; Xu L; Li D; Li F; Sun-Waterhouse D
Metabolites; 2022 Oct; 12(11):. PubMed ID: 36355111
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells.
Mencarelli A; Renga B; Palladino G; Claudio D; Ricci P; Distrutti E; Barbanti M; Baldelli F; Fiorucci S
Eur J Pharmacol; 2011 Oct; 668(1-2):317-24. PubMed ID: 21806984
[TBL] [Abstract][Full Text] [Related]
13. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
14. Atorvastatin reduces contrast media-induced pyroptosis of renal tubular epithelial cells by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
Yue RZ; Li YJ; Su BH; Li CJ; Zeng R
BMC Nephrol; 2023 Feb; 24(1):25. PubMed ID: 36732683
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Alginate and Chitosan Oligosaccharides against
Mavrogeni ME; Asadpoor M; Judernatz JH; van Ark I; Wösten MMSM; Strijbis K; Pieters RJ; Folkerts G; Braber S
Toxins (Basel); 2023 Sep; 15(10):. PubMed ID: 37888617
[No Abstract] [Full Text] [Related]
16. Xianglian Pill attenuates ulcerative colitis through TLR4/MyD88/NF-κB signaling pathway.
Dai Y; Lu Q; Li P; Zhu J; Jiang J; Zhao T; Hu Y; Ding K; Zhao M
J Ethnopharmacol; 2023 Jan; 300():115690. PubMed ID: 36075274
[TBL] [Abstract][Full Text] [Related]
17. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of toll-like receptor 4 with TLR4-IN-C34 modulates the intestinal flora homeostasis and the MyD88/NF-κB axis in ulcerative colitis.
Chen Y; Li D; Sun L; Qi K; Shi L
Eur J Pharmacol; 2022 Nov; 934():175294. PubMed ID: 36152840
[TBL] [Abstract][Full Text] [Related]
19. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
20. Activation of intestinal human pregnane X receptor protects against azoxymethane/dextran sulfate sodium-induced colon cancer.
Cheng J; Fang ZZ; Nagaoka K; Okamoto M; Qu A; Tanaka N; Kimura S; Gonzalez FJ
J Pharmacol Exp Ther; 2014 Dec; 351(3):559-67. PubMed ID: 25277138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
